Friday, November 10, 2017 6:07:30 PM
Jonathan Maltz, Ph.D., Chief Scientific Advisor
Dr. Maltz, received his PhD degree in Electrical Engineering from the University of California at
Berkeley, and has over 16 years of experience designing new devices for assessing vascular
function and evaluating these on human subjects. Dr Maltz is author of over 25 peer-reviewed
publications, and holds 18 granted US patents.
Jeffrey Olgin, M.D., Medical Advisor
Dr. Jeffrey Olgin, a cardiologist and electrophysiologist, is co-director of the UCSF Heart and
Vascular Center and chief of Cardiology. A specialist in the treatment of arrhythmias, he has
developed treatment techniques for irregular heartbeats and founded the UCSF Atrial Arrhythmia
Clinic that provides comprehensive patient care and studies genetic links in atrial fibrillation.
Greg Robertson, M.D., Medical Advisor
Dr. Greg Robertson is chief of the Emory Heart and Vascular Clinic at Johns Creek. At the Emory
Johns Creek Hospital he is chief of cardiology and the medical director of the cardiac
catheterization laboratory and interventional program. He is board certified in Vascular Medicine,
Endovascular Medicine, Interventional Cardiology and Cardiovascular Medicine. He is an associate
professor of medicine at Emory University. Dr. Robertson’s clinical expertise has focused on
preventative care and using minimally-invasive vascular and cardiac treatment.
James Wall, M.D., Medical Advisor
Dr. James Wall is a practicing Pediatric Surgeon at Stanford University. He is an alumnus of the
Stanford Biodesign program and holds a Master's degree in Bioengineering. His current research
interest is in the design, development and analysis of health technology as well as the emerging
field of surgical endoscopy. James currently leads the surgical endoscopy program at Lucile
Packard Children’s Hospital and is the Assistant Director of the Biodesign Innovation Fellowship
for Stanford Biodesign.
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM